On July 20, China Life Insurance (02628.HK) rose 3.47% in regular trading, trading at HKD 27.5/share, with turnover of HKD 811 million.

On the news front, the insurance sector rallied broadly, with China Taiping up 7.19% and NCI up 5.97%, reflecting strong sector-wide momentum. China Life had previously issued a positive profit alert, forecasting H1 net profit attributable to shareholders of approximately RMB 128.9 billion to RMB 137.1 billion, representing a year-over-year increase of 215% to 235% — marking the first time its half-year profit exceeded RMB 100 billion. The company attributed the surge to deepened asset-liability coordination, optimized asset allocation, and strong investment returns.

Following the profit alert, the stock gapped up over 4% on July 15 to digest the positive news, then pulled back over 3% on July 17 due to profit-taking. The current rebound carries characteristics of a technical recovery. Major brokerages including UBS, JP Morgan, and Morgan Stanley have maintained Buy or Overweight ratings with target prices of HKD 38.9–40, though market participants remain divided on the sustainability of investment-driven earnings growth.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)